DVN
16
3
DD
56
3
DNB
78
6
C
58
-2
URI
53
-2
EXC
54
-2
PVH
52
-3
MRK
22
3
XEL
67
2
MA
55
-7
DE
46
3
NAVI
41
-3
ADP
64
2
UPS
41
-4
AMAT
36
5
MS
74
-2
QRVO
6
2
EXPE
88
2
ORLY
53
-3
EOG
58
2
DVN
16
3
DD
56
3
DNB
78
6
C
58
-2
URI
53
-2
EXC
54
-2
PVH
52
-3
MRK
22
3
XEL
67
2
MA
55
-7
DE
46
3
NAVI
41
-3
ADP
64
2
UPS
41
-4
AMAT
36
5
MS
74
-2
QRVO
6
2
EXPE
88
2
ORLY
53
-3
EOG
58
2
Financhill
Back

Armata Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Buy
51

ARMP
Armata Pharmaceuticals

Last Price:
2.10
Seasonality Move:
26.22%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Buy
51
Armata Pharmaceuticals (ARMP) is a Buy

Is Armata Pharmaceuticals a Buy, Sell or Hold?

  • The current Armata Pharmaceuticals [ARMP] share price is $2.09. The Score for ARMP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ARMP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARMP Stock Price Chart

What is Armata Pharmaceuticals's stock price today?

  • The Armata Pharmaceuticals share price today is $2.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARMP is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

ARMP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 40.94 Sell
Chaikin Money Flow: 3246 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.18 - 2.52) Sell
Bollinger Bands (100): (2.22 - 2.74) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ARMP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.39 Sell
20-day SMA: 2.35 Sell
50-day SMA: 2.32 Sell
200-day SMA: 2.8 Sell
8-day EMA: 2.28 Sell
20-day EMA: 2.33 Sell
50-day EMA: 2.37 Sell
200-day EMA: 2.61 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Armata Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):